Journal of Clinical Oncology , 0732-183X

Journal

11 - 20 out of 120Page size: 10

Publications

  1. 2019
  2. Published

    High-dose chemotherapy compared with standard chemotherapy and lung radiation in ewing sarcoma with pulmonary metastases: Results of the european ewing tumour working initiative of national groups, 99 trial and ewing 2008

    & 22 others, , Keith Wheatley, 1 Jan 2019, In: Journal of Clinical Oncology. 37, 34, p. 3192-3202 11 p.

    Research output: Contribution to journal › Article › peer-review

  3. 2018
  4. E-pub ahead of print

    High-dose chemotherapy and blood autologous stem-cell rescue compared with standard chemotherapy in localized high-risk Ewing sarcoma: results of Euro-E.W.I.N.G.99 and Ewing-2008

    6 Sep 2018, In: Journal of Clinical Oncology . 16 p.

    Research output: Contribution to journal › Article › peer-review

  5. E-pub ahead of print

    Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features

    Keith Wheatley, 28 Aug 2018, In: Journal of Clinical Oncology .

    Research output: Contribution to journal › Article › peer-review

  6. E-pub ahead of print

    Risk, risk factors and surveillance of subsequent malignant neoplasms in childhood cancer survivors: a review

    Raoul Reulen, 6 Jun 2018, In: Journal of Clinical Oncology . 36, 9 p.

    Research output: Contribution to journal › Article › peer-review

  7. E-pub ahead of print

    Development and validation of a combined metabolic and immune prognostic classifier for head and neck cancer

    Jill Brooks, Lucinda Archer, Rachel Spruce, Nikos Batis, Jennifer Bryant, Andrew Beggs, Daniel Tennant, Gary Middleton, Jean-Baptiste Cazier, Benjamin Willcox, 1 Jun 2018, In: Journal of Clinical Oncology. 36, 15 Suppl, p. 6049-6049

    Research output: Contribution to journal › Abstract › peer-review

  8. Published

    Measurable residual disease at induction redefines partial response in acute myeloid leukemia and stratifies outcomes in patients at standard risk without NPM1 mutations

    Sylvie Freeman, Naeem Khan, 20 May 2018, In: Journal of Clinical Oncology . 36, 15, p. 1486-1497 12 p.

    Research output: Contribution to journal › Article › peer-review

  9. Published

    Dasatinib in pediatric patients with chronic myeloid leukemia in chronic phase: results from a phase II trial

    Pamela Kearns, 1 May 2018, In: Journal of Clinical Oncology . 36, 13, p. 1330-1338 9 p.

    Research output: Contribution to journal › Article › peer-review

  10. Published

    Tumor PIK3CA genotype and prognosis in early-stage breast cancer: A pooled analysis of individual patient data

    & 12 others, , Daniel Rea, 1 Apr 2018, In: Journal of Clinical Oncology. 36, 10, p. 981-990 10 p.

    Research output: Contribution to journal › Article › peer-review

  11. Published

    Results of POUT: A phase III randomised trial of perioperative chemotherapy versus surveillance in upper tract urothelial cancer (UTUC)

    9 Feb 2018, In: Journal of Clinical Oncology . 36, Suppl 6S, Abstract 407.

    Research output: Contribution to journal › Abstract › peer-review

  12. 2017
  13. Published

    Improving outcomes in high-risk Myelodysplasia: Festina Lente

    Charles Craddock, 26 May 2017, In: Journal of Clinical Oncology . p. JCO2017730812

    Research output: Contribution to journal › Editorial › peer-review

Previous 1 2 3 4 5 6 7 8 ...12 Next